Vaccine effectiveness in preventing respiratory illness in Washington state (2022–2027)

Who could benefit from this research

What this research studies

As a current US Flu VE Network site, this project will continue to collect real-world data on how well vaccines prevent acute respiratory illness from influenza, COVID-19, and other respiratory viruses in Washington over the next five years. Researchers will analyze vaccination status, illness episodes, and health outcomes to estimate how vaccines reduce outpatient visits, hospitalizations, and severe illness. The study builds on existing surveillance infrastructure and uses real-world data to inform vaccination policies and public health decisions, with a focus on timely reporting to policymakers. Participants may include patients seeking care for respiratory symptoms and health data will be linked to vaccination records.

Why it matters

Where this research is happening

• Kaiser Foundation Health Plan of Washington
  Seattle, United States Active

Researchers

• Principal investigator: Wernli, Karen J — Kaiser Foundation Health Plan of Washington
• Study coordinator: Wernli, Karen J

Related research

Other NIH-funded projects on the same topics.

• Understanding flu and COVID-19 vaccine responses in people and in the lab

  Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.

  NIH research Stanford University · Stanford, United States · NIH-11591264

• Burden and consequences of influenza, SARS-CoV-2 and other respiratory viruses among Indian adults

  This grant aims to study how flu and COVID-19 and related respiratory infections affect Indian adults 18–60, including costs, outcomes, and vaccine uptake to inform health policy.

  NIH research All-India Institute of Medical Sciences · New Delhi, India · NIH-11388782

• Leptin and fat cells: how obesity may worsen lung infections like COVID-19 and flu

  A study explores how fat tissue and the leptin pathway might change the body's first lung defenses during respiratory infections in people who are obese or have diabetes.

  NIH research Louisiana State Univ A&m Col Baton Rouge · Baton Rouge, United States · NIH-11382855

• Understanding flu and COVID-19 vaccine responses in adults

  A Stanford-led effort studies how the flu and COVID-19 vaccines work in adults and how to make them work better for people, especially those with higher risk from underlying health conditions.

  NIH research Stanford University · Stanford, United States · NIH-11333210

• How flu, COVID-19, and other respiratory vaccines protect people in Washington from sudden respiratory illness

  This project checks how well seasonal flu, COVID-19, and other respiratory vaccines prevent short-term respiratory illnesses in people living in Washington state.

  NIH research Kaiser Foundation Health Plan of Washington · Seattle, United States · NIH-11170380

• Tracking serious influenza, COVID-19, and other respiratory infections in working-age Indian adults

  This project follows adults aged 18–60 in India who get severe respiratory infections to find out how often they happen, what long-term problems and costs result, and how well vaccines protect against serious illness.

  NIH research All-India Institute of Medical Sciences · New Delhi, India · NIH-11137548

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.